FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

22980411000001102: Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Sep 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1855841000001113 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1855851000001111 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Is a Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has active ingredient Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has active ingredient Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has AMP True Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start